column
Note by the Guest Editors
,
2024, 41(9): Ⅰ-Ⅱ.
Abstract PDF
Re-searching nasopharyngeal carcinoma
Ingemar Ernberg, ZHENG Shixing, ZHOU Xiaoying
2024, 41(9): 1227-1236. DOI: 10.16190/j.cnki.45-1211/r.2024.09.001
Abstract PDF
Advancements in the epidemiology of nasopharyngeal carcinoma
DU Yun, ZHANG Chao, FENG Ruimei, HUANG Tingting, LI Jianjun, ZHANG Zhe, YE Weimin
2024, 41(9): 1237-1246. DOI: 10.16190/j.cnki.45-1211/r.2024.09.002
Abstract PDF
Screening for nasopharyngeal carcinoma in high-incidence regions——Next steps
Allan Hildesheim
2024, 41(9): 1247-1251. DOI: 10.16190/j.cnki.45-1211/r.2024.09.003
Abstract PDF
The role of EBV lytic genes in tumor development and progression
DENG Yizhang, ZHONG Qian
2024, 41(9): 1252-1260. DOI: 10.16190/j.cnki.45-1211/r.2024.09.004
Abstract PDF
The role of glycoproteins in nasopharyngeal carcinoma pathogenesis
Liudmila Matskova, Elvira Grigorieva
2024, 41(9): 1261-1272. DOI: 10.16190/j.cnki.45-1211/r.2024.09.005
Abstract PDF
The prognostic predictive value of indirect bilirubin-inflammation score in patients with nasopharyngeal carcinoma
JI Huojin, LI Jun, LUO Yonglin, QIN Weiling, YE Yinxin, CAI Yonglin
2024, 41(9): 1273-1281. DOI: 10.16190/j.cnki.45-1211/r.2024.09.006
Abstract PDF
BDH2 inhibits MIF and affects the recruitment of macrophages by nasopharyngeal carcinoma
SU Jiaming, TANG Shiyue, HUANG Guangwu, ZHANG Zhe
2024, 41(9): 1282-1288. DOI: 10.16190/j.cnki.45-1211/r.2024.09.007
Abstract PDF
Early diagnosis and personalized comprehensive treatment of nasopharyngeal carcinoma based on Epstein-Barr virus-specific markers
CHEN Jie, LIANG Shuming, LIU Liting, MAI Haiqiang
2024, 41(9): 1289-1295. DOI: 10.16190/j.cnki.45-1211/r.2024.09.008
Abstract PDF
Current status and prospects of immunotherapy for locally advanced nasopharyngeal carcinoma
LIU Xixi, SUN Yajie, YANG Kunyu
2024, 41(9): 1296-1303. DOI: 10.16190/j.cnki.45-1211/r.2024.09.009
Abstract PDF
Early prediction value of ASL-MRI for induced chemotherapy response and short-term efficacy of locally advanced nasopharyngeal carcinoma
SHEN Mingjun, YANG Chaolin, ZHOU Ziyan, WANG Rensheng, KANG Min
2024, 41(9): 1304-1310. DOI: 10.16190/j.cnki.45-1211/r.2024.09.010
Abstract PDF
Current research status on prediction and prevention of temporal lobe injury after intensitymodulated radiotherapy for nasopharyngeal carcinoma
WANG Zekun, LIU Weixin, XIAO Shaowen
2024, 41(9): 1311-1315. DOI: 10.16190/j.cnki.45-1211/r.2024.09.011
Abstract PDF
Research progress in surgical treatment of recurrent nasopharyngeal carcinoma
ZHENG Shixing, ZHANG Huankang, XUE Kai, LI Wanpeng, GU Ye, LIU Quan, SUN Xicai, YU Hong meng
2024, 41(9): 1316-1324. DOI: 10.16190/j.cnki.45-1211/r.2024.09.012
Abstract PDF